• MCC950 Sodium: Precision NLRP3 Workflow Guide

  2026-09-10

  MCC950 sodium enables selective interrogation of NLRP3 signaling while preserving complementary inflammatory readouts such as TNF-α. This guide translates macrophage, endotoxemia, extracellular-vesicle, and autoimmune disease workflows into practical assay designs with time-course controls and troubleshooting strategies.

• dNTP Control Points in Translational LNP Research

  2026-09-09

  A mechanistic guide to using a defined dNTP mixture as an analytical control in nucleic acid delivery programs, informed by evidence linking LNP surface charge with target-cell V-ATPase activity.

• Bafilomycin C1 in Mechanism-Aware Phenotypic Screens

  2026-09-09

  Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that can turn lysosomal acidification into an interpretable variable in advanced cell assays. This article connects V-ATPase biology with deep-learning phenotypic screening and practical strategies for separating mechanism from nonspecific toxicity.

• Moxifloxacin: From Gyrase Mechanism to Translation

  2026-09-08

  Moxifloxacin is more than a broad-spectrum fluoroquinolone antibiotic: it is a useful translational probe linking bacterial DNA topology, mammalian cell responses, and systemic metabolic signals. This article outlines a mechanism-aware strategy for antibiotic toxicity research, interprets retinal ganglion cell and rat findings cautiously, and shows how structural work on gepotidacin can sharpen experimental design without conflating distinct compounds.

• Mitochondrial Repair in Diabetic Periodontitis

  2026-09-08

  The reference study introduces a hierarchically targeted, ROS-responsive hydrogel that delivers MitoQ to mitochondria within M1 macrophages in diabetic periodontitis. Its results support a treatment strategy that combines local retention, inflammation-triggered release, mitochondrial repair, and restoration of the periodontal bone-forming environment.

• Drug Repurposing for CRISPR DNA Repair Control

  2026-09-07

  This study screened 7,240 drug conditions in human induced pluripotent stem cells to identify compounds that shift CRISPR-induced double-strand break repair toward NHEJ, MMEJ, or HDR. The work also implicates ESR2 and AOX1 in repair regulation and provides a framework for combining pharmacological perturbation with genome editing and synthetic-lethality studies.

• Homoharringtonine N1504: Reliable Cell Assays

  2026-09-07

  This scenario-based guide explains how Homoharringtonine (SKU N1504) can support reproducible viability, proliferation, leukemia research, and SARS-CoV-2 antiviral research workflows. It covers mechanism, solvent compatibility, assay optimization, interpretation, and practical product-selection criteria grounded in product specifications and peer-reviewed evidence.

• EZ Cap EGFP mRNA 5-moUTP: Assay Design

  2026-09-05

  EZ Cap EGFP mRNA 5-moUTP is more than a fluorescent reporter: its cap, modified uridine, and poly(A) architecture make it a practical probe for separating delivery from translation. This guide shows how to use enhanced green fluorescent protein mRNA to design more interpretable cellular and in vivo assays.

• Oleic Acid C18:1(9Z) Assay Workflows

  2026-09-04

  Build reproducible hepatocyte lipid-loading, signaling, inflammation, and cancer assays with Oleic Acid C18:1(9Z). This workflow emphasizes controlled fatty-acid delivery, mechanistic readouts, matched controls, and troubleshooting for translating liver-injury findings into practical bench experiments.

• CGP 55845 Hydrochloride in GABAB Translation

  2026-09-04

  A translational framework for using CGP 55845 hydrochloride to separate GABAB receptor signaling from astrocytic GAT-3 mechanisms in synaptic transmission research, neurotransmitter release modulation, and hypoglycemia mechanism study workflows.

• Cycloastragenol in Glucocorticoid-Induced Osteonecrosis

  2026-09-03

  The 2024 Journal of Orthopaedic Translation study shows that cycloastragenol protects against methylprednisolone-associated femoral-head damage in rats by restraining osteoclast activity, preserving trabecular structure, and improving local blood supply. Its value is mechanistic as well as therapeutic: the work links glucocorticoid-induced osteonecrosis to altered RANKL–OPG signaling and provides a framework for evaluating bone-preserving interventions.

• Cefiderocol Against Resistant European Nonfermenters

  2026-09-03

  This European surveillance study directly compared cefiderocol with established and emerging β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa and Acinetobacter spp., including meropenem-resistant isolates. Its combination of broad isolate sampling, resistance stratification, PCR, and whole-genome sequencing shows why cefiderocol susceptibility testing may retain value when conventional options are compromised.

• Ambroxol Targets Nav1.8, TRPV1, and TRPA1

  2026-09-02

  This 2025 Journal of Pain study defines a multi-target electrophysiological profile for ambroxol, showing species-dependent Nav1.8 inhibition alongside weaker modulation of human TRPV1 and TRPA1. Its findings provide a mechanistic rationale for topical analgesia while highlighting why rodent Nav1.8 data should not be transferred directly to human pain biology.

• Bestatin as a Chemical Genetics Tool for Jasmonate Signaling

  2026-09-02

  The reference study established Bestatin as a chemical probe for jasmonate signaling in Arabidopsis and tomato, rather than merely as an aminopeptidase inhibitor. By combining gene-expression analysis, pharmacological comparisons, developmental phenotyping, and screening for bestatin-resistant mutants, the authors identified regulators and response classes that help dissect COI1-dependent jasmonate biology.

• 25-Hydroxycholesterol Reprograms Tumor Macrophages

  2026-09-01

  Xiao et al. identify CH25H and lysosomal 25-hydroxycholesterol as an immunometabolic checkpoint that connects sterol handling to AMPKα–STAT6 signaling in tumor-associated macrophages. The study shows that targeting this axis can improve T-cell surveillance and enhance anti-PD-1 efficacy, providing a mechanistic framework for studying macrophage-mediated tumor immune suppression.

8123 records 1/542 page Next 12345 下5页 Last page